miRNA 221 improved left ventricular contractile function in MIRI mice. by Hongyu Li (1332669)

Subjects:

The percentage of received patients who migrated for primary knee arthroplasty in different provinces. by Fanqiang Meng (4786071)

Subjects:

Flowchart of analysis. by Fanqiang Meng (4786071)

Subjects:

Patient migration rates for primary knee arthroplasty from 2013 to 2018. by Fanqiang Meng (4786071)

Subjects:

Comparison of postoperative outcomes and financial burden between migrated and non-migrated primary knee arthroplasty patients. by Fanqiang Meng (4786071)

Subjects:

Sankey diagram of patient migration for primary knee arthroplasty in China. by Fanqiang Meng (4786071)

Subjects:

Demographics of patients who underwent primary knee arthroplasty during 2013 to 2018. by Fanqiang Meng (4786071)

Subjects:

Baseline characteristics of propensity score-matched migrated and non-migrated primary knee arthroplasty patients. by Fanqiang Meng (4786071)

Subjects:

The percentage of patients who migrated to outside provinces for primary knee arthroplasty in different provinces. by Fanqiang Meng (4786071)

Subjects:

Regression plot showing how effort discounting <i>k</i> increases linearly (Spearman <i>rho</i>) with reported CLBP intensity. by Samuel Alldritt (22097240)

Innovation and night light in large and small cities. by Saul Estrin (8629173)

Between the PCSO-524 group and the placebo group unpaired comparisons of the change between visits of quality of life and respiratory variables scores. by Nattapon Riengvirodkij (11268720)

Subjects:

A flow diagram outlining the number of dogs in each group during the study (visit 1 = day 0, visit 2 = day 35, and visit 3 = day 70). by Nattapon Riengvirodkij (11268720)

Subjects:

Distribution of quality of life and respiratory variables scores of all 3 visits (visit = day 0, visit 2 = day 35, and visit 3 = day 70) of the PCSO-524 group and the placebo group... by Nattapon Riengvirodkij (11268720)

Subjects:

The baseline characteristics of classifications and body condition score of the 2 groups (frequencies) at entry (visit 1, day 0). by Nattapon Riengvirodkij (11268720)

Subjects:

Distribution of continuous variables of all 3 visits (visit 1 = day 0, visit 2 = day 35, and visit 3 = day 70) of the PCSO-524 group and the placebo group. Results are shown as mea... by Nattapon Riengvirodkij (11268720)

Subjects:

Tricuspid regurgitation pressure gradient of all 17 dogs. by Nattapon Riengvirodkij (11268720)

Subjects:

Tricuspid regurgitation pressure gradient in the PCSO-524 and placebo groups. by Nattapon Riengvirodkij (11268720)

Subjects:

Data. by Aroon La-up (14095691)

Subjects:

Significant associations in GWAS. by Dai Nogimura (21445649)

Subjects: